Anixa Biosciences, Inc. (ANIX)
NASDAQ: ANIX · IEX Real-Time Price · USD
3.180
+0.110 (3.58%)
Apr 24, 2024, 4:00 PM EDT - Market closed
Anixa Biosciences Market Cap
Anixa Biosciences has a market cap or net worth of $101.44 million as of April 25, 2024. Its market cap has decreased by -27.28% in one year.
Market Cap
101.44M
Enterprise Value
77.81M
1-Year Change
-27.28%
Ranking
Category
Stock Price
$3.18
Market Cap Chart
Since December 1, 1998, Anixa Biosciences's market cap has increased from $83.20M to $101.44M, an increase of 21.92%. That is a compound annual growth rate of 0.78%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Apr 23, 2024 | 97.90M | 1.98% |
Apr 22, 2024 | 96.00M | -3.52% |
Apr 19, 2024 | 99.50M | 0.61% |
Apr 18, 2024 | 98.90M | 1.64% |
Apr 17, 2024 | 97.30M | -3.76% |
Apr 16, 2024 | 101.10M | 0.30% |
Apr 15, 2024 | 100.80M | -0.30% |
Apr 12, 2024 | 101.10M | -1.56% |
Apr 11, 2024 | 102.70M | 0.59% |
Apr 10, 2024 | 102.10M | -1.54% |
Apr 9, 2024 | 103.70M | 2.57% |
Apr 8, 2024 | 101.10M | -0.98% |
Apr 5, 2024 | 102.10M | 1.90% |
Apr 4, 2024 | 100.20M | -4.21% |
Apr 3, 2024 | 104.60M | 2.45% |
Apr 2, 2024 | 102.10M | -4.49% |
Apr 1, 2024 | 106.90M | 7.44% |
Mar 28, 2024 | 99.50M | -3.40% |
Mar 27, 2024 | 103.00M | 3.21% |
Mar 26, 2024 | 99.80M | -3.11% |
Mar 25, 2024 | 103.00M | -6.70% |
Mar 22, 2024 | 110.40M | -6.20% |
Mar 21, 2024 | 117.70M | -1.09% |
Mar 20, 2024 | 119.00M | 3.66% |
Mar 19, 2024 | 114.80M | 2.50% |
View and export this data all the way back to 1998.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Elicio Therapeutics | 99.55M |
KORU Medical Systems | 99.20M |
Envoy Medical | 98.78M |
Aurora Cannabis | 98.76M |
Myomo | 98.00M |
BioXcel Therapeutics | 95.85M |
DiaMedica Therapeutics | 95.27M |
IO Biotech | 94.87M |